Group 1 - The company has approved the use of idle self-owned funds for cash management, with a maximum balance of up to RMB 1 billion [1] - The cash management will involve investing in low to medium-risk financial products with good liquidity and safety [1] - The company will strictly adhere to prudent investment principles and select short-term investment products from banks and securities companies [1] Group 2 - The company has purchased various structured deposit products, including the "Tianlibao" structured deposit from Hangzhou Bank, with expected annualized returns ranging from 0.65% to 2.15% [4][5][8] - The investment amounts for these structured deposits include RMB 10 million, RMB 13 million, and RMB 50 million, among others [4][5][8] - The company has no related party relationships with the banks involved in these investments [4][5][8] Group 3 - In the past twelve months, the company has used idle self-owned funds to purchase financial products with a cumulative amount of RMB 553 million that have not yet matured [9] - The company will implement risk control measures to manage investment risks associated with cash management [9]

Fundraising Overview - The company raised a total of RMB 525.36 million by issuing 22 million shares at RMB 23.88 per share, with a net amount of RMB 446.17 million after deducting issuance costs of RMB 79.19 million, which was deposited into a dedicated fundraising account on February 10, 2023 [1][2] - As of December 31, 2024, the balance in the fundraising account was RMB 4.27 million, with a total of RMB 44.62 million raised and utilized for various projects and working capital [2][3] Fund Utilization - The company allocated RMB 7.21 million for project investments and RMB 8 million for working capital, with an additional RMB 1.2 million from oversubscribed funds permanently supplementing working capital [2][3] - The total amount utilized for project investments reached RMB 10.30 million, while the cash management activities generated a net interest income of RMB 1.46 million [2][3] Fund Management - The company established a fundraising management system to ensure compliance with relevant regulations and protect investor interests, including a tripartite supervision agreement with banks and the sponsor [3][4] - As of December 31, 2024, the company had not used idle fundraising for temporary working capital and had engaged in cash management with a balance of RMB 24.65 million, primarily in high-security, liquid investment products [4][5] Project Status and Adjustments - The company approved the use of RMB 6.68 million of fundraising to replace pre-invested project funds and RMB 0.57 million for issuance costs [4][5] - The high-end optical lens intelligent manufacturing project and the R&D center upgrade project have been delayed, with the expected completion date adjusted to December 2026 due to market conditions and project progress [8][9] Compliance and Audit - The company has adhered to all relevant laws and regulations regarding fundraising usage, with no violations reported [10][11] - The sponsor confirmed that the management of fundraising and its usage complied with regulatory requirements, with no changes in the purpose of the funds that could harm shareholder interests [11]